Literature DB >> 14904949

Psychiatric aspects of somatic immunity; differential incidence of physical disease in the histories of psychiatric patients.

J W L DOUST.   

Abstract

Entities:  

Keywords:  MENTAL DISORDERS

Mesh:

Year:  1952        PMID: 14904949      PMCID: PMC1037327          DOI: 10.1136/jech.6.1.49

Source DB:  PubMed          Journal:  Br J Soc Med        ISSN: 0366-0842


× No keyword cloud information.
  7 in total

1.  Physical Disorder in 164 Admissions to a Mental Hospital.

Authors:  R J Phillips
Journal:  Br Med J       Date:  1937-08-21

2.  The use and misuse of the chi-square test.

Authors:  D LEWIS; C J BURKE
Journal:  Psychol Bull       Date:  1949-11       Impact factor: 17.737

3.  Relation of nutritional deficiency in man to antibody production.

Authors:  H H BALCH
Journal:  J Immunol       Date:  1950-05       Impact factor: 5.422

4.  The incidence of certain vegetative disturbances in relation to psychosis.

Authors:  W D ROSS; J HAY; M F McDOWALL
Journal:  Psychosom Med       Date:  1950 May-Jun       Impact factor: 4.312

5.  Psychotic factors in psychosomatic illness.

Authors:  J APPEL; S R ROSEN
Journal:  Psychosom Med       Date:  1950 Jul-Aug       Impact factor: 4.312

6.  Illness experience of a group of normal children.

Authors:  L M BAYER; M M SNYDER
Journal:  Child Dev       Date:  1950-06

7.  Immunity and schizophrenia; a survey of the ability of schizophrenic patients to develop an active immunity following the injection of pertussis vaccine.

Authors:  W T VAUGHAN; J C SULLIVAN; F ELMADJIAN
Journal:  Psychosom Med       Date:  1949 Nov-Dec       Impact factor: 4.312

  7 in total
  2 in total

Review 1.  General susceptibility to illness: a selective review.

Authors:  H J Thurlow
Journal:  Can Med Assoc J       Date:  1967-12-02       Impact factor: 8.262

2.  Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients.

Authors:  L E DeLisi; J R Ortaldo; A E Maluish; R J Wyatt
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.